Cargando…

Rifampicin for Treatment of Cholestatic Pruritus Caused by Drug-Induced Acute Liver Injury as Assessed by the RUCAM Classification

A male bodybuilder of 39 years of age developed severe pruritus, nausea, and jaundice after injecting anabolic steroids purchased on the black market. The patient had no history of liver disease and no risk factors for viral hepatitis. Extensive laboratory testing, radiographic imaging, and liver bi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmadi, Ali R., Chicco, Maria, van den Berge, Marcel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429806/
https://www.ncbi.nlm.nih.gov/pubmed/32832174
http://dx.doi.org/10.1155/2020/8872804
_version_ 1783571321690521600
author Ahmadi, Ali R.
Chicco, Maria
van den Berge, Marcel
author_facet Ahmadi, Ali R.
Chicco, Maria
van den Berge, Marcel
author_sort Ahmadi, Ali R.
collection PubMed
description A male bodybuilder of 39 years of age developed severe pruritus, nausea, and jaundice after injecting anabolic steroids purchased on the black market. The patient had no history of liver disease and no risk factors for viral hepatitis. Extensive laboratory testing, radiographic imaging, and liver biopsy excluded a majority of potential pathologies. The patient was diagnosed with drug-induced acute liver injury and secondary acute renal failure most likely caused by testosterone purchased on the black market. The pruritus caused insomnia and significant psychological distress. Treatment was initiated with cholestyramine and naltrexone for one week with no effect on the pruritus. Subsequently, all medications were stopped, and rifampicin was started. Pruritus resolved after starting rifampicin, and liver and kidney function improved rapidly and normalized within 5 months.
format Online
Article
Text
id pubmed-7429806
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-74298062020-08-20 Rifampicin for Treatment of Cholestatic Pruritus Caused by Drug-Induced Acute Liver Injury as Assessed by the RUCAM Classification Ahmadi, Ali R. Chicco, Maria van den Berge, Marcel Case Reports Hepatol Case Report A male bodybuilder of 39 years of age developed severe pruritus, nausea, and jaundice after injecting anabolic steroids purchased on the black market. The patient had no history of liver disease and no risk factors for viral hepatitis. Extensive laboratory testing, radiographic imaging, and liver biopsy excluded a majority of potential pathologies. The patient was diagnosed with drug-induced acute liver injury and secondary acute renal failure most likely caused by testosterone purchased on the black market. The pruritus caused insomnia and significant psychological distress. Treatment was initiated with cholestyramine and naltrexone for one week with no effect on the pruritus. Subsequently, all medications were stopped, and rifampicin was started. Pruritus resolved after starting rifampicin, and liver and kidney function improved rapidly and normalized within 5 months. Hindawi 2020-08-07 /pmc/articles/PMC7429806/ /pubmed/32832174 http://dx.doi.org/10.1155/2020/8872804 Text en Copyright © 2020 Ali R. Ahmadi et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Ahmadi, Ali R.
Chicco, Maria
van den Berge, Marcel
Rifampicin for Treatment of Cholestatic Pruritus Caused by Drug-Induced Acute Liver Injury as Assessed by the RUCAM Classification
title Rifampicin for Treatment of Cholestatic Pruritus Caused by Drug-Induced Acute Liver Injury as Assessed by the RUCAM Classification
title_full Rifampicin for Treatment of Cholestatic Pruritus Caused by Drug-Induced Acute Liver Injury as Assessed by the RUCAM Classification
title_fullStr Rifampicin for Treatment of Cholestatic Pruritus Caused by Drug-Induced Acute Liver Injury as Assessed by the RUCAM Classification
title_full_unstemmed Rifampicin for Treatment of Cholestatic Pruritus Caused by Drug-Induced Acute Liver Injury as Assessed by the RUCAM Classification
title_short Rifampicin for Treatment of Cholestatic Pruritus Caused by Drug-Induced Acute Liver Injury as Assessed by the RUCAM Classification
title_sort rifampicin for treatment of cholestatic pruritus caused by drug-induced acute liver injury as assessed by the rucam classification
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429806/
https://www.ncbi.nlm.nih.gov/pubmed/32832174
http://dx.doi.org/10.1155/2020/8872804
work_keys_str_mv AT ahmadialir rifampicinfortreatmentofcholestaticprurituscausedbydruginducedacuteliverinjuryasassessedbytherucamclassification
AT chiccomaria rifampicinfortreatmentofcholestaticprurituscausedbydruginducedacuteliverinjuryasassessedbytherucamclassification
AT vandenbergemarcel rifampicinfortreatmentofcholestaticprurituscausedbydruginducedacuteliverinjuryasassessedbytherucamclassification